REGISTERED AND RENEWED
on 13 Nov 2024
Last Applicant/ Owned by
8 rue de la Croix
Paris
FR
75013
Serial Number
76210655 filed on 13th Feb 2001
Registration Number
2872075 registered on 10th Aug 2004
Correspondent Address
Mary Margaret L. O'Donnell
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CELLECTIS
Scientific and industrial research; research in genetic, medical, pharmaceutical and veterinary fields; research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis; research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques; research and development for others of new molecules intended for indu Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific and industrial research; research in genetic, medical, pharmaceutical and veterinary fields; research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis; research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; medical services; studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; testing, analysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for others, development for others of multimedia software programs
First Use Date in General
30th Jun 2000
First Use Date in Commerce
30th Nov 2000
Class [009]
Computer & Software Products & Electrical & Scientific Products
[ Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniques, namely automated biochemical analyser, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyser, analyzer for automatically measuring and researching interactions of biomolecules, device for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-tests, qualitative and quantitative detection of analytes in samples, namely, DNA sequencing, receptor-ligand interaction, protein analysis, mass-spectrometry, nucleic acid hybridization and detection, thermo-cycler systems, microarray-printer, microarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipment, namely, computer software for molecular design, sequence analysis, sequence generation, design and analysis for molecules, namely polypeptides or polynucleotides used in genetic engineering, design and analysis of meganucleases and endonucleases and for design and analysis of genetic recombination systems, hardware and component parts, namely, processors, memory banks, peripheral controllers; multimedia products, namely, prerecorded magnetic tapes, CD-ROMs, containing image and sound recordings in the fields of chemistry, biology, biochemistry, molecular biology, bacteriology; software programs namely, software for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searching, retrieving, storing, maintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysis, nucleic acids and proteins sequences evaluation, chemical, medical and biological data bank searches and analysis, physiological data analysis, genetic data analysis, chemical formulae analysis, structural prediction for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysis, simulation and design of biological, chemical, and material systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modeling, analysis and information management; software for integrated global management ]
First Use Date in General
31st Aug 2001
First Use Date in Commerce
31st Aug 2001
Class [005]
Pharmaceutical Products
Pharmaceutical, veterinary and health-care products, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganulease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medical, pharmaceutical and veterinary use, namely microoganisms engineered by meganuclease recombination system for use in genetic or viral diseases, cancers and vaccines; microorganisms producing polypeptides for in vivo and vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medical, pharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system; drugs for veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic and acid vectors, molecular scissors for use in genetic or viral diseases; biological preparation for medical, pharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleaes, nucleic and vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use
First Use Date in General
31st Aug 2001
First Use Date in Commerce
31st Aug 2001
Class [001]
Chemical Products
Chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination system, namely, meganuclease recombination agents for use in genetic engineering of cells and animals, namely rodent and fish , for scientific, laboratory or medical research; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; chemical, biochemical, biotechnological products and bacteriological preparations for sciences, namely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; diagnostic preparation, namely natural and engineered meganucleases and endonucleases, molecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medical, pharmaceutical and veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for scientific or research use
First Use Date in General
31st Aug 2001
First Use Date in Commerce
31st Aug 2001
Mark Details
Serial Number
No 76210655
Mark Type
No Service Mark
Attorney Docket Number
No SANT-0343/US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 13th Nov 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 13th Nov 2024 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
| 10th Nov 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 12th Aug 2024 | TEAS SECTION 8 & 9 RECEIVED |
| 18th Oct 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 18th Oct 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 18th Oct 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 18th Oct 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 18th Oct 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |